Expertise in translational research in inflammatory disease

We bridge fundamental discoveries and clinical application by offering broad expertise in cellular and in vivo models of inflammatory and infectious diseases, supporting mechanistic studies and preclinical testing of novel therapeutic strategies. We also have access to multiple longitudinal patient cohorts, providing clinical data and biological samples for biomarker discovery and validation.

What we offer

• Established cellular and in vivo models of inflammatory and infectious diseases

• Mechanistic studies to understand disease pathways and therapeutic targets

• Preclinical testing and validation of novel therapies and drug candidates

• Access to multiple longitudinal patient cohorts, with clinical data and biological samples

• Support for biomarker discovery, validation and patient stratification

What we are looking for

• Academic and clinical partners to expand research on inflammatory and infectious diseases

• Industry partners interested in preclinical evaluation of compounds, therapies or diagnostics

• Consortia and joint proposals for funding under Horizon Europe